Companies see a commercial opportunity in creating new ways to administer drugs to patients – in space.

Daraxonrasib doubles survival — a RAS‑targeting drug development breakthrough. Daraxonrasib doubled median survival versus ...

Critical Path Institute® (C-Path) will host its 2026 Global Impact Conference (CGIC) this September at the Washington ...

Snowflake (NYSE: SNOW), the AI Data Cloud company, today announced at Snowflake Summit 26 that Sanofi, one of the world's ...

AstraZeneca CEO Pascal Soriot said AI is helping the company develop medicines faster and make smarter decisions throughout ...

Shattuck Labs has secured $54.9 million in new funding. Operating in the biotech sector can be challenging, but the lab has enhanced its financial position at a ...

Building on its legacy of standardizing LC separation, Evosep now extends upstream to sample preparation, delivering complete ...

BostonGene, developer of the leading AI model for tumor and immune biology, today announced it has been named a Diamond winner in the 2026 Pinnacle Awards for Healthcare. Recognized in the Innovator ...

In this week’s edition of InnovationRx, we look at a new AI drug development deal, a pill for sleep apnea, Commure’s $7 ...

Discover how quality-driven drug development and AI accelerate safer medicines, reduce risk, and improve patient outcomes.

There has been much discussion recently about how artificial intelligence and machine learning (AI/ML) will revolutionize pharmaceutical research. Substantial progress has been made in the discovery ...

Big Pharma is pouring money into tech-devised treatments, but the verdict is out on whether they’ll actually work.